[Pharmacologic characterization of vascular barriers against erythrocytes and albumin].
D000818:Animals; D001485:Basement Membrane / Q000187:drug effects; D002199:Capillary Permeability; D002859:Chromium Isotopes; D002918:Chymotrypsin / Q000494:pharmacology; D004912:Erythrocytes; D006470:Hemorrhage / Q000139:chemically induced; D006636:Histamine Release; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D007678:Kidney Glomerulus / Q000187:drug effects; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008297:Male; D003012:Microbial Collagenase; D011817:Rabbits; D051381:Rats; D012709:Serum Albumin / Q000378:metabolism*; D012711:Serum Albumin, Radio-Iodinated; D014357:Trypsin / Q000494:pharmacology; D014688:Venoms
D002859:Chromium Isotopes; D008244:Lysophosphatidylcholines; D012709:Serum Albumin; D012711:Serum Albumin, Radio-Iodinated; D014688:Venoms; D006821:Hyaluronoglucosaminidase; D002918:Chymotrypsin; D014357:Trypsin; D003012:Microbial Collagenase
Pharmakologische Charakterisierung der vasculären Schrankenfunktion gegenüber Erythrocyten und Albumin.